Reuters logo
6 months ago
BRIEF-Alcobra Ltd says pre-ind meeting with FDA held on Alcobra's proprietary abuse-deterrent, amphetamine immediate release (ADAIR) product candidate
February 6, 2017 / 9:34 PM / 6 months ago

BRIEF-Alcobra Ltd says pre-ind meeting with FDA held on Alcobra's proprietary abuse-deterrent, amphetamine immediate release (ADAIR) product candidate

Feb 6 (Reuters) - Alcobra Ltd

* Alcobra Ltd says pre-ind meeting with FDA held on Alcobra's proprietary abuse-deterrent, amphetamine immediate release (ADAIR) product candidate

* Alcobra Ltd says meeting defined a 505(b)(2) development path, to be funded with existing cash balance, and targeting a 2H 2018 NDA submission Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below